Editas Medicine (EDIT) Tops Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts EDIT Hot Sheet
Join SI Premium – FREE
Editas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.67), $0.15 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.99 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Ennis (EBF) Misses Q2 EPS by 2c
- Bernstein SocGen Group Starts Amphenol (APH) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
